LIEPHARM
InactiveInactive; last annual accounts for fiscal year 2023.
Signals
Two signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Two or more financial years not filed
Since the financial year that closed on 31-12-2024, 2 financial years are missing at the National Bank. A company this far behind goes bankrupt within the year nineteen times as often as a punctual filer.
NBB · 9 filingsPosition against the passed deadline
31-12-2024 close31-07-2025 deadline28-09-2026 today
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2023 was due by 31-07-2024 and was filed on 25-07-2024, 6 days ahead of the deadline.
NBB · 9 filingsDeviation from the deadline
2025
not confirmed
2024
not filed
2023
6 d early
2022
19 d early
2021
11 d early
2020
44 d early
2019
20 d late
← before the deadline
after the deadline →
tick = median of all Belgian filings
This company filed its last 5 accounts on average 12 days before the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.
Checked, nothing found (1)
Financials · fiscal year 2023, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€45,375▼ 10.2%
2022 · €50,524
Working capital
€266,723▲ 23.6%
2022 · €215,752
Trend over the years
Click a name to add, emphasise or remove a line.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20192020202120222023
Operating result€47,187▼ 28.8%€98,199▲ 108%€21,087▼ 78.5%€71,108▲ 237%€63,919▼ 10.1%
Net result€27,633▼ 33.3%€72,570▲ 163%€11,372▼ 84.3%€50,524▲ 344%€45,375▼ 10.2%
Equity€101,517▲ 37.4%€174,087▲ 71.5%€185,458▲ 6.5%€235,982▲ 27.2%€281,357▲ 19.2%
Total assets€1.3m▲ 11.4%€1.4m▲ 9.8%€1.6m▲ 14.8%€1.5m▼ 10.9%€1.5m▲ 0.5%
Debt€1.2m▲ 9.6%€1.3m▲ 4.6%€1.5m▲ 16.0%€1.2m▼ 15.7%€1.2m▼ 3.1%
Working capital€73,619▲ 50.4%€224,217▲ 205%€188,302▼ 16.0%€215,752▲ 14.6%€266,723▲ 23.6%
Staff (FTE)1.2▲ 9.1%1.4▲ 16.7%2.1▲ 50.0%3▲ 42.9%3=
Result per fiscal year
Operating resultNet result
The operating result falls in 2023; 2023 is 10% below 2022.
Balance-sheet composition
2023 in colour, 2022 as the grey bar beneath
Assets €1.5m
Fixed assets
€20,968 ▼ 40.9%
Current assets
€1.5m ▲ 1.5%
Equity and liabilities €1.5m
Equity
€281,357 ▲ 19.2%
Debt
€1.2m ▼ 3.1%
Debt's share of the balance-sheet total falls from 83.9% to 80.9%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€78,413▼
2022 · €85,878
Cash flow
€59,869▼
2022 · €65,293
Current ratio
1.22▲
2022 · 1.18
Quick ratio
0.92▲
2022 · 0.87
Debt to equity
4.24▼
2022 · 5.22
ROE
16.1%▼
2022 · 21.4%
ROA
3.1%▼
2022 · 3.4%
Interest coverage
27.04▲
2022 · 23.42
Debt ≤ 1 year
€1.2m▼
2022 · €1.2m
Debt > 1 year
€6,334▼
2022 · €15,232
Income taxes
€15,660▼
2022 · €17,064
Staff costs
€134,385▲
2022 · €91,156
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | Change |
|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | - | - | €66,880 | €91,156 | €134,385 | ▲ 47.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €7,090 | €10,331 | €14,770 | €14,770 | €14,494 | ▼ 1.9% |
| Other operating charges640/8 | - | - | €420 | €638 | €419 | ▼ 34.4% |
| Gross operating margin9900 | €102,418 | €157,642 | €103,157 | €177,672 | €213,217 | ▲ 20.0% |
| Operating profit (loss)9901 | €47,187 | €98,199 | €21,087 | €71,108 | €63,919 | ▼ 10.1% |
| Financial income75/76B | - | - | €383 | €146 | €15 | ▼ 89.5% |
| Recurring financial income75 | €294 | €253 | €383 | €146 | €15 | ▼ 89.5% |
| Financial charges65/66B | - | - | €5,904 | €3,666 | €2,899 | ▼ 20.9% |
| Recurring financial charges65 | €4,780 | €5,544 | €5,904 | €3,666 | €2,899 | ▼ 20.9% |
| Profit (loss) for the period before taxes9903 | €42,702 | €92,907 | €15,566 | €67,587 | €61,035 | ▼ 9.7% |
| Income taxes67/77 | €15,069 | €20,338 | €4,194 | €17,064 | €15,660 | ▼ 8.2% |
| Profit (loss) for the period9904 | €27,633 | €72,570 | €11,372 | €50,524 | €45,375 | ▼ 10.2% |
| Profit (loss) for the period to be appropriated9905 | €27,633 | €72,570 | €11,372 | €50,524 | €45,375 | ▼ 10.2% |
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €1.3m | €1.4m | €1.6m | €1.5m | €1.5m | ▲ 0.5% |
| Fixed assets21/28 | €28,092 | €65,001 | €50,232 | €35,462 | €20,968 | ▼ 40.9% |
| Intangible fixed assets21 | €2,625 | €2,100 | €1,575 | €1,050 | €525 | ▼ 50.0% |
| Tangible fixed assets22/27 | €25,467 | €62,901 | €48,657 | €34,412 | €20,443 | ▼ 40.6% |
| Plant, machinery and equipment23 | - | - | €3,820 | €3,263 | €2,706 | ▼ 17.1% |
| Furniture and vehicles24 | - | - | €31,409 | €22,176 | €13,218 | ▼ 40.4% |
| Other tangible fixed assets26 | - | - | €13,428 | €8,973 | €4,519 | ▼ 49.6% |
| Current assets29/58 | €1.3m | €1.4m | €1.6m | €1.4m | €1.5m | ▲ 1.5% |
| Stocks and contracts in progress3 | €311,158 | €362,861 | €357,580 | €375,372 | €362,213 | ▼ 3.5% |
| Stocks30/36 | - | - | €357,580 | €375,372 | €362,213 | ▼ 3.5% |
| Amounts receivable within one year40/41 | €892,699 | €980,834 | €936,110 | €847,812 | €936,226 | ▲ 10.4% |
| Trade receivables40 | - | - | €936,110 | €819,070 | €906,885 | ▲ 10.7% |
| Other amounts receivable41 | - | - | - | €28,742 | €29,341 | ▲ 2.1% |
| Cash at bank and in hand54/58 | €73,182 | €21,581 | €298,571 | €203,006 | €150,700 | ▼ 25.8% |
| Deferred charges and accrued income490/1 | - | - | €3,017 | €4,993 | €3,456 | ▼ 30.8% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €1.3m | €1.4m | €1.6m | €1.5m | €1.5m | ▲ 0.5% |
| Equity10/15 | €101,517 | €174,087 | €185,458 | €235,982 | €281,357 | ▲ 19.2% |
| Contributions10/11 | €21,000 | - | €21,000 | €21,000 | €21,000 | = |
| Reserves13 | €57,100 | €122,100 | €137,100 | €187,100 | €187,100 | = |
| Non-distributable reserves130/1 | - | - | €2,100 | €2,100 | - | - |
| Reserves not available under the articles1311 | - | - | €2,100 | €2,100 | - | - |
| Distributable reserves133 | - | - | €135,000 | €185,000 | €187,100 | ▲ 1.1% |
| Profit (loss) carried forward14 | €23,417 | €30,987 | €27,358 | €27,882 | €73,257 | ▲ 163% |
| Amounts payable17/49 | €1.2m | €1.3m | €1.5m | €1.2m | €1.2m | ▼ 3.1% |
| Amounts payable after more than one year17 | - | €115,131 | €52,206 | €15,232 | €6,334 | ▼ 58.4% |
| Financial debts170/4 | - | - | €52,206 | €15,232 | €6,334 | ▼ 58.4% |
| Amounts payable within one year42/48 | €1.2m | €1.1m | €1.4m | €1.2m | €1.2m | ▼ 2.4% |
| Current portion of amounts payable after more than one year42 | - | - | €62,138 | €37,277 | €9,970 | ▼ 73.3% |
| Financial debts43 | - | - | - | €25,000 | €25,000 | = |
| Credit institutions430/8 | - | - | - | €25,000 | €25,000 | = |
| Trade debts44 | €750,485 | €681,370 | €1.0m | €871,407 | €785,536 | ▼ 9.9% |
| Suppliers440/4 | - | - | €1.0m | €871,407 | €785,536 | ▼ 9.9% |
| Taxes, remuneration and social security45 | - | - | €10,890 | €10,332 | €39,150 | ▲ 279% |
| Taxes450/3 | - | - | €5,358 | €5,208 | €22,496 | ▲ 332% |
| Remuneration and social security454/9 | - | - | €5,531 | €5,124 | €16,654 | ▲ 225% |
| Other amounts payable47/48 | - | - | €300,764 | €271,415 | €326,215 | ▲ 20.2% |
| Accrued charges and deferred income492/3 | - | - | €869 | - | - | - |
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €27,633 | €72,570 | €11,372 | €50,524 | €45,375 | ▼ 10.2% |
| + Depreciation and write-downs630 | €7,090 | €10,331 | €14,770 | €14,770 | €14,494 | ▼ 1.9% |
| Operating cash flow (approximation) | €34,723 | €82,901 | €26,141 | €65,293 | €59,869 | ▼ 8.3% |
| Investment in fixed assets (approximation) | - | -€47,240 | €0 | €0 | €0 | - |
| Change in cash | - | -€51,601 | €276,990 | -€95,564 | -€52,306 | ▲ 45.3% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2024
25-07
NBB filing
Annual accounts filed
fiscal year 2023 · full schema
2023
12-07
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
2022
31-12
Financial
Equity above €200,000Eq €235,982 ▲27.2%
5 profitable years in a row build equity to €235,982.
20-07
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
2021
31-12
Financial
Weakest financial yearnet €11,372 ▼84.3%
Net result drops to €11,372, the lowest in the series.
17-06
NBB filing
Annual accounts filed
fiscal year 2020 · full schema
2020
31-12
Financial
Highest result since 2018net €72,570 ▲163%
Operating result €98,199, net result €72,570, both a record.
31-12
Financial
Equity above €150,000Eq €174,087 ▲71.5%
3 profitable years in a row build equity to €174,087.
20-08
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 20 days late
2019
31-12
Financial
Equity above €100,000Eq €101,517 ▲37.4%
2 profitable years in a row build equity to €101,517.
30-07
NBB filing
Annual accounts filed
fiscal year 2018 · full schema
2018
20-08
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 20 days late
2017
30-08
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 30 days late
2016
21-08
NBB filing
Annual accounts filed
fiscal year 2015 · full schema · 21 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 5 acts read
About the unread acts
We know of 5 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Structure & network
Owners and holdings
Owners 0
No owner stated in the accounts, acts or LEI register we read.
Stated earlier (1)
An older source named these owners; newer accounts no longer list them.
-
100%
Holdings 0
The accounts to 31-12-2022 list no holdings, and no other source names one.
According to the 2022 annual accounts of LIEPHARM and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.